Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$1,141.93	$83,491,746,043
	22,362,850	$1,141.93	$25,536,809,301
	17,233,668	$1,141.93	$19,679,642,500
	14,567,176	$1,141.93	$16,634,695,290
	9,033,726	$1,141.93	$10,315,882,732
	8,998,338	$1,141.93	$10,275,472,113
	8,322,140	$1,141.93	$9,503,301,331
	8,009,729	$1,141.93	$9,146,549,837
	7,619,135	$1,141.93	$8,700,518,831
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

OnCusp Therapeutics Announces Appointment of Robert Forrester and Chau Khuong to Board of Directors Jan 4, 2023 08:00AM

Chau Khuong Joins Catalio Capital Management as General Partner May 25, 2022 03:00PM

Intellia Therapeutics Announces Second Quarter 2017 Financial Results Aug 1, 2017 07:30AM

Intellia Therapeutics (NTLA) Appoints Moncef Slaoui and Frank Verweil to Board Jul 25, 2017 05:46AM

Intellia Therapeutics Names Moncef Slaoui, Ph.D. and Frank Verwiel, M.D. to Its Board of Directors and Establishes a Science and Technology Committee Jul 24, 2017 06:30PM

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed